Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:33:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new drug information and identifiers related to RET fusion-positive non-small cell lung cancer, while removing detailed descriptions of a previous study involving pralsetinib.
    Difference
    21%
    Check dated 2025-04-16T20:53:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025. However, there are no significant changes in core content, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-04-09T16:09:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of February 6, 2025.
    Difference
    0.3%
    Check dated 2025-04-02T00:34:57.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:18:33.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The webpage has added several new healthcare locations in Italy, including specific hospitals and their addresses, while removing some previously listed locations and dates. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.
    Difference
    7%
    Check dated 2025-02-10T16:47:31.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.